KeyAxis™ turns sixteen-plus years of pharmaceutical key-account practice — the ACCESS Method™ — into software that guides emerging biopharma from institutional account intelligence to confirmed access.
Institutional account modeling & scoring across IDNs, hospital systems, specialty pharmacies, and institutional buyers.
Joint Business Plan co-construction — sequenced, not blank. Objectives, milestones, service commitments, cadence, sign-off.
Institutional and public purchasing workflow — from requirement mapping to award decision, governed end-to-end.
High-cost and specialty-therapy access programs — hub coordination, eligibility logic, patient-access economics.
The weekly-review discipline consolidated into one live governance view across every module output.
The ACCESS Method™ — versioned and continuously updated. Every subscribing team receives the current method.
Data passes forward between modules; the Methodology Library governs the rules at every step.
Built for IDNs, hospital systems, specialty pharmacies, and institutional buyers — the entities that actually govern U.S. access.
Gives a single-asset team the institutional-access discipline it has never had.
The tier most emerging commercial teams settle on as they scale across accounts.
Serves multi-product organizations coordinating institutional access nationally.
"The JBP Studio was the first time our team ran a joint business plan the way IDN customers actually expect to be engaged."
"We stopped losing tenders on documentation gaps. The Navigator's readiness meter is now the discipline of the team."
"As a first commercial hire, KeyAxis™ gave me the operating method I would have taken three years to build alone."